| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/04/2011 | CN102038958A Nano particle composition and application thereof |
| 05/04/2011 | CN102038936A Application of SIRT1 (silent mating type information regulation-1) in preparing upregulation globin gene expression and preparing medicine for curing anemia |
| 05/04/2011 | CN101920022B Specific anti-virus antisense nucleic acid medicament for avian influenza virus |
| 05/04/2011 | CN101638655B Carcinoembryonic antigen positive cell targeted gene expression element CPE and application thereof |
| 05/04/2011 | CN101560521B Constructing method of VA1-missing adenovirus vector for expressing small interfering RNA (siRNA) |
| 05/04/2011 | CN101555253B Ruthenium polypyridyl complex inducing DNA to condense, preparation method and application thereof |
| 05/04/2011 | CN101525626B Expression vector containing IER5 gene, monoclonal cell line and application thereof |
| 05/04/2011 | CN101418309B Cloning, expression and application of eimeria tenella protein disulfide isomerase gene |
| 05/04/2011 | CN101366949B Method for improving feed efficiency and/or growth rate and/or fat reduction of livestock |
| 05/04/2011 | CN101244268B Eimeria Tenella complex immunity regulation type DNA vaccine |
| 05/03/2011 | US7935813 siRNA target hypoxia-inducible factor 1 |
| 05/03/2011 | US7935812 A composition comprising two double stranded nucleic acid molecules ; nucleic acids with a pyrimidine modification |
| 05/03/2011 | US7935808 Recombinant expression vector elements (rEVEs) for enhancing expression of recombinant proteins in host cells |
| 05/03/2011 | US7935805 Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| 05/03/2011 | US7935718 Treatment of dyskinesia |
| 05/03/2011 | US7935678 Therapeutic use of CPG oligodeoxynucleotide for skin disease |
| 05/03/2011 | US7935676 Nucleic acid construct containing a nucleic acid derived from the genome of hepatitis C virus (HCV) of genotype 2A, and a cell having such nucleic acid construct introduced therein |
| 05/03/2011 | US7935675 Immunostimulatory nucleic acid molecules |
| 05/03/2011 | US7935528 Liver stem cell |
| 05/03/2011 | US7935491 Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer |
| 05/03/2011 | US7935353 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 05/03/2011 | US7935333 Vaccine against brain protein; antiepileptic agents |
| 05/03/2011 | CA2458626C Lipid derivatives of aminoglycosides |
| 05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
| 05/03/2011 | CA2378586C Replication-competent anti-cancer vectors |
| 05/03/2011 | CA2350776C Novel mitogenic regulators |
| 05/03/2011 | CA2347066C Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof |
| 05/03/2011 | CA2342966C Gene alteration in the gene for the gbeta3 subunit of the human g protein |
| 05/03/2011 | CA2293805C Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 05/03/2011 | CA2262525C Methods of treating pulmonary diseases mediated by polyunsaturated lipid metabolites and assays for epoxide hydrolase inhibitors |
| 04/28/2011 | WO2011050211A2 Methods and compositions for cell-proliferation-related disorders |
| 04/28/2011 | WO2011050000A2 Single molecule nucleic acid nanoparticles |
| 04/28/2011 | WO2011049346A2 Compositions for improving migration potential of stem cells |
| 04/28/2011 | WO2011049059A1 Composition comprising rna-enclosing carrier |
| 04/28/2011 | WO2011048589A2 Ion exchangers and methods of use thereof |
| 04/28/2011 | WO2011047631A1 Proteins or polypeptides with cd137l function and genes encoding the same and uses thereof |
| 04/28/2011 | WO2011006070A3 Genetic association of polymorphisms in perilipin (plin) gene with resistance to weight loss |
| 04/28/2011 | WO2010036960A8 Methods for treating, diagnosing, and monitoring lupus |
| 04/28/2011 | WO2009134681A3 Adeno associated viral vectors for targeted transduction of retinal pigment epithetial cells |
| 04/28/2011 | US20110098460 SiRNA Useful to Suppress expression of eIF-5A1 |
| 04/28/2011 | US20110098214 Lps or lipid a binding agent and novel peptide |
| 04/28/2011 | US20110097794 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
| 04/28/2011 | US20110097726 Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 04/28/2011 | US20110097389 P53 biomarkers |
| 04/28/2011 | CA2793836A1 Methods and compositions for cell-proliferation-related disorders |
| 04/27/2011 | EP2314716A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/27/2011 | EP2314708A1 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 04/27/2011 | EP2314699A1 Medical preparations for the treatment of alpha-galactosidase A deficiency |
| 04/27/2011 | EP2314693A2 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
| 04/27/2011 | EP2314692A2 Methods and compositions for enhancing the efficacy and specificity of RNAi |
| 04/27/2011 | EP2314691A2 Fuctional and hyperfunctional siRNA |
| 04/27/2011 | EP2314690A1 RNA-interference by single-stranded RNA molecules |
| 04/27/2011 | EP2314673A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 04/27/2011 | EP2314622A1 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 04/27/2011 | EP2314612A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314611A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314610A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314595A2 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 04/27/2011 | EP2314322A1 Compositions containing genetically modified lung cancer cells expressing a TGF-beta inhibitor |
| 04/27/2011 | EP2314321A1 Formulations comprising antisense nucleotides to connexins |
| 04/27/2011 | EP2314310A2 Identification of surface-associated antigens for tumour diagnosis and therapy |
| 04/27/2011 | EP2314309A2 Identification of surface-associated antigens for tumour diagnosis and therapy |
| 04/27/2011 | EP2314306A1 Biological pacemaker |
| 04/27/2011 | EP2039367B1 Prophylactic/therapeutic agent for neurodegenerative disease |
| 04/27/2011 | EP1930436B1 Vector for delivering target substance into nucleus or cell |
| 04/27/2011 | EP1732947B1 Growth factor binding constructs materials and methods |
| 04/27/2011 | EP1317470B1 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate tumor therapy |
| 04/27/2011 | EP1257292B1 Use of il-18 inhibitors |
| 04/27/2011 | EP0972031B1 Procollagen assembly |
| 04/27/2011 | CN102036690A Novel soluble CD83 polypeptides, formulations and methods of use |
| 04/27/2011 | CN102036689A Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneration |
| 04/27/2011 | CN102036688A Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells |
| 04/27/2011 | CN102036677A Heat shock protein GP96 vaccination and methods of using same |
| 04/27/2011 | CN102031310A Application of miRNA-195/497 compounds jointly as breast cancer markers |
| 04/27/2011 | CN102031309A Application of miRNA-34c compound as brain glioma marker |
| 04/27/2011 | CN102031308A Application of miRNA-29a compound as brain glioma marker |
| 04/27/2011 | CN102031269A Method for preparing cationic amino acid-containing polypeptide-modified nano calcium phosphate gene vector |
| 04/27/2011 | CN102031260A Short interfering ribonucleic acid (siRNA) for promoting scarless healing of skin wounds and application thereof |
| 04/27/2011 | CN102031256A Human miR-485-5p antisense nucleic acid and application thereof |
| 04/27/2011 | CN102031255A Antisense nucleic acid of human miR-223 and applications of antisense nucleic acid |
| 04/27/2011 | CN102031254A Human miR-150 antisense nucleic acid and application thereof |
| 04/27/2011 | CN102030822A New human cell factor VSTM1-v2 and application thereof |
| 04/27/2011 | CN102030754A Non-viral vector, and preparation method and application thereof |
| 04/27/2011 | CN102028958A Composite tumor gene vaccine taking bacterial nano magnetosome as carrier and preparation method thereof |
| 04/27/2011 | CN102028957A Application of BTG2 (B cell translocation gene 2) in preparing radiation sensitizing agent |
| 04/27/2011 | CN102028956A Application of BTG2 (B Cell Translocation Gene 2) in preparing medicament for inhibiting cancer transfer |
| 04/27/2011 | CN102028955A Novel targeting compound for tumor gene interference |
| 04/27/2011 | CN102028954A Preparation of recombinant adenovirus |
| 04/27/2011 | CN102028947A Inhibitor, inhibitor composition and inhibiting method of FAM3B gene, fatty liver treatment method and pharmaceutical application of inhibitor |
| 04/27/2011 | CN102028942A Application of Escherichia coli in fish vaccine |
| 04/27/2011 | CN101597338B Mannan-containing ligand and preparation method and application thereof |
| 04/27/2011 | CN101434629B SiRNA sequence inhibiting human Akt2 gene expression and fusion expression vector |
| 04/27/2011 | CN101255418B Human heparinase RNA interference target sequence and uses thereof |
| 04/27/2011 | CN101172994B Small disturbance RNA of interleukin 17 acceptor mIL-17RE gene, encoding gene and application of the same |
| 04/26/2011 | US7932373 Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 04/26/2011 | US7932350 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 04/26/2011 | US7932234 Bispecific oligonucleotide for the treatment of CNS malignancies |
| 04/26/2011 | US7932066 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 04/26/2011 | US7931893 A pseudotyped feline immunodeficiency virus virion; transfection; expression vectors packaged in packaging cells to generate high titer recombinant virus stocks; gene therapy |
| 04/26/2011 | CA2488414C Primary cultured adipocytes for gene therapy |